HALEON PLC
LSE:HLN
Intrinsic Value
HALEON PLC is a GB-based company operating in Personal Products industry. [ Read More ]
The intrinsic value of one HLN stock under the Base Case scenario is 340.13 GBX. Compared to the current market price of 334.4 GBX, HALEON PLC is Undervalued by 2%.
Valuation Backtest
HALEON PLC
Run backtest to discover the historical profit from buying and selling HLN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
HALEON PLC
Current Assets | 4.8B |
Cash & Short-Term Investments | 1B |
Receivables | 1.9B |
Other Current Assets | 1.8B |
Non-Current Assets | 29.2B |
PP&E | 1.9B |
Intangibles | 26.9B |
Other Non-Current Assets | 480m |
Current Liabilities | 4.6B |
Accounts Payable | 3.5B |
Short-Term Debt | 60m |
Other Current Liabilities | 1.1B |
Non-Current Liabilities | 12.8B |
Long-Term Debt | 8.8B |
Other Non-Current Liabilities | 4B |
Earnings Waterfall
HALEON PLC
Revenue
|
11.3B
GBP
|
Cost of Revenue
|
-4.3B
GBP
|
Gross Profit
|
7B
GBP
|
Operating Expenses
|
-4.4B
GBP
|
Operating Income
|
2.5B
GBP
|
Other Expenses
|
-1.5B
GBP
|
Net Income
|
1B
GBP
|
Free Cash Flow Analysis
HALEON PLC
HLN Profitability Score
Profitability Due Diligence
HALEON PLC's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
HALEON PLC's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
HLN Solvency Score
Solvency Due Diligence
HALEON PLC's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
HALEON PLC's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HLN Price Targets Summary
HALEON PLC
According to Wall Street analysts, the average 1-year price target for HLN is 369.39 GBX with a low forecast of 318.15 GBX and a high forecast of 430.5 GBX.
Shareholder Return
HLN Price
HALEON PLC
Average Annual Return | -2.12% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -25% |
Market Capitalization | 30.9B GBX |
Shares Outstanding | 9 132 301 000 |
Percentage of Shares Shorted |
N/A
|
HLN News
Last Important Events
HALEON PLC
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
HALEON PLC
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
HALEON PLC is a GB-based company operating in Personal Products industry. The company is headquartered in Brentford, Middlesex and currently employs 22,800 full-time employees. The company went IPO on 2022-07-18. Haleon plc is a consumer healthcare company. The firm's product portfolio is divided among five categories: Oral Health; Pain Relief; vitamins, minerals and supplements (VMS); Respiratory Health; Digestive Health, and Other. Its portfolio of brands includes Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax and Centrum. In addition, the Company also has local strategic brands, which include TUMS, ENO, Flonase, ChapStick, Emergen-C, Fenbid, Grand-Pa, and Dr.BEST. The firm operates its business units in three regions: North America; Europe, Middle East, and Africa (EMEA) and Latin America (LatAm), and Asia-Pacific (APAC).
Contact
IPO
Employees
Officers
The intrinsic value of one HLN stock under the Base Case scenario is 340.13 GBX.
Compared to the current market price of 334.4 GBX, HALEON PLC is Undervalued by 2%.